日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Perceived vs. objective frailty in patients with atrial fibrillation and impact on anticoagulant dosing: an ETNA-AF-Europe sub-analysis

房颤患者的感知虚弱与客观虚弱及其对抗凝药物剂量的影响：ETNA-AF-Europe 子分析

期刊:Europace
影响因子:7.4
doi:10.1093/europace/euac004
Diemberger, Igor; Fumagalli, Stefano; Mazzone, Anna Maria; Bakhai, Ameet; Reimitz, Paul Egbert; Pecen, Ladislav; Manu, Marius Constantin; Gordillo de Souza, José Antonio; Kirchhof, Paulus; De Caterina, Raffaele
发表日期：2022
文献求助 收藏

Retrospective OSL Dosimetry With Common Pharmaceuticals and Food Supplements

常用药物和食品补充剂的回顾性 OSL 剂量测定

期刊:Frontiers in Public Health
影响因子:3.4
doi:10.3389/fpubh.2022.908016
Ekendahl, Daniela; Reimitz, Dan
发表日期：2022
文献求助 收藏

Periprocedural anticoagulation in the uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation (ELIMINATE-AF) trial

在不间断使用依度沙班与维生素K拮抗剂治疗房颤的消融术（ELIMINATE-AF）试验中，围手术期抗凝治疗的效果如何？

期刊:Europace
影响因子:7.4
doi:10.1093/europace/euaa199
Hohnloser, Stefan H; Camm, A John; Cappato, Riccardo; Diener, Hans-Christoph; Heidbüchel, Hein; Mont, Lluís; Morillo, Carlos A; Lanz, Hans-Joachim; Rauer, Heiko; Reimitz, Paul-Egbert; Smolnik, Rüdiger; Kautzner, Josef
发表日期：2021
文献求助 收藏

Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: 1-year follow-up of the prospective observational ETNA-AF-Europe study

在常规临床护理中，使用艾多沙班预防房颤患者卒中：前瞻性观察性 ETNA-AF-Europe 研究的 1 年随访

期刊:European Heart Journal-Cardiovascular Pharmacotherapy
影响因子:6.1
doi:10.1093/ehjcvp/pvaa079
de Groot, Joris R; Weiss, Thomas W; Kelly, Peter; Monteiro, Pedro; Deharo, Jean Claude; de Asmundis, Carlo; López-de-Sá, Esteban; Waltenberger, Johannes; Steffel, Jan; Levy, Pierre; Bakhai, Ameet; Zierhut, Wolfgang; Laeis, Petra; Manu, Marius Constantin; Reimitz, Paul-Egbert; De Caterina, Raffaele; Kirchhof, Paulus
发表日期：2021
文献求助 收藏

Folding DNA into origami nanostructures enhances resistance to ionizing radiation

将DNA折叠成折纸纳米结构可增强其对电离辐射的抵抗力

期刊:Nanoscale
影响因子:5.1
doi:10.1039/d1nr02013g
Sala, Leo; Zerolová, Agnes; Rodriguez, Alvaro; Reimitz, Dan; Davídková, Marie; Ebel, Kenny; Bald, Ilko; Kočišek, Jaroslav
发表日期：2021
文献求助 收藏

Clinical risk predictors in atrial fibrillation patients following successful coronary stenting: ENTRUST-AF PCI sub-analysis

冠状动脉支架植入术后房颤患者的临床风险预测因素：ENTRUST-AF PCI 亚组分析

期刊:Clinical Research in Cardiology
影响因子:3.7
doi:10.1007/s00392-020-01760-4
Goette, Andreas; Eckardt, Lars; Valgimigli, Marco; Lewalter, Thorsten; Laeis, Petra; Reimitz, Paul-Egbert; Smolnik, Rüdiger; Zierhut, Wolfgang; Tijssen, Jan G; Vranckx, Pascal
发表日期：2021
文献求助 收藏

Factors associated with the dosing of edoxaban for stroke prevention in patients with atrial fibrillation from South Korea and Taiwan: 1-year data from the Global ETNA-AF Program

韩国和台湾房颤患者使用依度沙班预防卒中剂量相关的因素：来自全球 ETNA-AF 项目的 1 年数据

期刊:
影响因子:
doi:10.1097/JCMA.0000000000000516
Chao, Tze-Fan; Hong, Keun-Sik; Lee, Byung-Chul; De Caterina, Raffaele; Kirchhof, Paulus; Reimitz, Paul-Egbert; Chen, Cathy; Unverdorben, Martin; Wang, Chun-Chieh
发表日期：2021
文献求助 收藏

Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial

在接受经皮冠状动脉介入治疗的房颤患者中，使用艾多沙班治疗急性或慢性冠状动脉综合征：ENTRUST-AF PCI试验的预设分析

期刊:European Heart Journal
影响因子:35.6
doi:10.1093/eurheartj/ehaa617
Vranckx, Pascal; Valgimigli, Marco; Eckardt, Lars; Lewalter, Thorsten; Unikas, Ramunas; Marin, Francisco; Schiele, François; Laeis, Petra; Reimitz, Paul-Egbert; Smolnik, Rüdiger; Zierhut, Wolfgang; Tijssen, Jan; Goette, Andreas
发表日期：2020
文献求助 收藏

Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe)

欧洲接受依度沙班治疗的患者特征：欧洲房颤 (AF) 患者在常规临床实践中接受依度沙班治疗的基线数据 (ETNA-AF-Europe)

期刊:BMC Cardiovascular Disorders
影响因子:2.3
doi:10.1186/s12872-019-1144-x
De Caterina, Raffaele; Kelly, Peter; Monteiro, Pedro; Deharo, Jean Claude; de Asmundis, Carlo; López-de-Sá, Esteban; Weiss, Thomas W; Waltenberger, Johannes; Steffel, Jan; de Groot, Joris R; Levy, Pierre; Bakhai, Ameet; Zierhut, Wolfgang; Laeis, Petra; Kerschnitzki, Michael; Reimitz, Paul-Egbert; Kirchhof, Paulus
发表日期：2019
文献求助 收藏

The global Edoxaban Treatment in routine cliNical prActice (ETNA) noninterventional study program: rationale and design

全球常规临床实践中应用艾多沙班治疗（ETNA）非干预性研究项目：原理和设计

期刊:Clinical Cardiology
影响因子:2.3
doi:10.1002/clc.23279
De Caterina, Raffaele; Agnelli, Giancarlo; Laeis, Petra; Unverdorben, Martin; Rauer, Heiko; Wang, Chun-Chieh; Nakamura, Mashio; Chiu, Kuan-Ming; Reimitz, Paul-Egbert; Koretsune, Yukihiro; Chen, Cathy; Thee, Ulrike; Kaburagi, Jumpei; Kim, Young-Hoon; Choi, Won-Il; Yamashita, Takeshi; Cohen, Alexander; Kirchhof, Paulus
发表日期：2019
文献求助 收藏